[(2R,3R,4S)-2-(2-amino-6-chloropurin-9-yl)-5-ethyl-4-methyl-5-(methylsulfonyloxymethyl)oxolan-3-yl] acetate

C16H22ClN5O6S — CID 118633386

IUPAC[(2R,3R,4S)-2-(2-amino-6-chloropurin-9-yl)-5-ethyl-4-methyl-5-(methylsulfonyloxymethyl)oxolan-3-yl] acetate
SMILESCCC1(COS(C)(=O)=O)O[C@@H](n2cnc3c(Cl)nc(N)nc32)[C@H](OC(C)=O)[C@@H]1C
InChIInChI=1S/C16H22ClN5O6S/c1-5-16(6-26-29(4,24)25)8(2)11(27-9(3)23)14(28-16)22-7-19-10-12(17)20-15(18)21-13(10)22/h7-8,11,14H,5-6H2,1-4H3,(H2,18,20,21)/t8-,11+,14+,16?/m0/s1
InChIKeyDYRMMKGRXJULGQ-CAMJAJLSSA-N
MW447.90 g/mol
LogP1.28
Rot. Bonds6

About [(2R,3R,4S)-2-(2-amino-6-chloropurin-9-yl)-5-ethyl-4-methyl-5-(methylsulfonyloxymethyl)oxolan-3-yl] acetate

[(2R,3R,4S)-2-(2-amino-6-chloropurin-9-yl)-5-ethyl-4-methyl-5-(methylsulfonyloxymethyl)oxolan-3-yl] acetate (PubChem CID 118633386) has the molecular formula C16H22ClN5O6S and a molecular weight of 447.90 g/mol. Its IUPAC name is [(2R,3R,4S)-2-(2-amino-6-chloropurin-9-yl)-5-ethyl-4-methyl-5-(methylsulfonyloxymethyl)oxolan-3-yl] acetate.

Molecular Properties

Compound Name[(2R,3R,4S)-2-(2-amino-6-chloropurin-9-yl)-5-ethyl-4-methyl-5-(methylsulfonyloxymethyl)oxolan-3-yl] acetate
PubChem CID118633386
Molecular FormulaC16H22ClN5O6S
Molecular Weight447.90 g/mol
Exact Mass447.10
IUPAC Name[(2R,3R,4S)-2-(2-amino-6-chloropurin-9-yl)-5-ethyl-4-methyl-5-(methylsulfonyloxymethyl)oxolan-3-yl] acetate
SMILESCCC1(COS(C)(=O)=O)O[C@@H](n2cnc3c(Cl)nc(N)nc32)[C@H](OC(C)=O)[C@@H]1C
InChIInChI=1S/C16H22ClN5O6S/c1-5-16(6-26-29(4,24)25)8(2)11(27-9(3)23)14(28-16)22-7-19-10-12(17)20-15(18)21-13(10)22/h7-8,11,14H,5-6H2,1-4H3,(H2,18,20,21)/t8-,11+,14+,16?/m0/s1
InChIKeyDYRMMKGRXJULGQ-CAMJAJLSSA-N
XLogP1.28
TPSA148.52 Ų
H-Bond Donors1
H-Bond Acceptors11
Rotatable Bonds6
Heavy Atoms29
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500447.90
LogP ≤ 51.28
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Sulfonic_acid_1', 'substructure': 'N/A'}

Analyze [(2R,3R,4S)-2-(2-amino-6-chloropurin-9-yl)-5-ethyl-4-methyl-5-(methylsulfonyloxymethyl)oxolan-3-yl] acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(2R,3R,4S)-2-(2-amino-6-chloropurin-9-yl)-5-ethyl-4-methyl-5-(methylsulfonyloxymethyl)oxolan-3-yl] acetate?
The IUPAC name of [(2R,3R,4S)-2-(2-amino-6-chloropurin-9-yl)-5-ethyl-4-methyl-5-(methylsulfonyloxymethyl)oxolan-3-yl] acetate (CID 118633386) is [(2R,3R,4S)-2-(2-amino-6-chloropurin-9-yl)-5-ethyl-4-methyl-5-(methylsulfonyloxymethyl)oxolan-3-yl] acetate.
What is the SMILES notation for [(2R,3R,4S)-2-(2-amino-6-chloropurin-9-yl)-5-ethyl-4-methyl-5-(methylsulfonyloxymethyl)oxolan-3-yl] acetate?
The canonical SMILES for [(2R,3R,4S)-2-(2-amino-6-chloropurin-9-yl)-5-ethyl-4-methyl-5-(methylsulfonyloxymethyl)oxolan-3-yl] acetate is CCC1(COS(C)(=O)=O)O[C@@H](n2cnc3c(Cl)nc(N)nc32)[C@H](OC(C)=O)[C@@H]1C.
What is the InChIKey of [(2R,3R,4S)-2-(2-amino-6-chloropurin-9-yl)-5-ethyl-4-methyl-5-(methylsulfonyloxymethyl)oxolan-3-yl] acetate?
The InChIKey is DYRMMKGRXJULGQ-CAMJAJLSSA-N. The full InChI is InChI=1S/C16H22ClN5O6S/c1-5-16(6-26-29(4,24)25)8(2)11(27-9(3)23)14(28-16)22-7-19-10-12(17)20-15(18)21-13(10)22/h7-8,11,14H,5-6H2,1-4H3,(H2,18,20,21)/t8-,11+,14+,16?/m0/s1.
What are the key properties of [(2R,3R,4S)-2-(2-amino-6-chloropurin-9-yl)-5-ethyl-4-methyl-5-(methylsulfonyloxymethyl)oxolan-3-yl] acetate?
[(2R,3R,4S)-2-(2-amino-6-chloropurin-9-yl)-5-ethyl-4-methyl-5-(methylsulfonyloxymethyl)oxolan-3-yl] acetate has a molecular weight of 447.90 g/mol, XLogP of 1.28, 6 rotatable bonds, 1 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for [(2R,3R,4S)-2-(2-amino-6-chloropurin-9-yl)-5-ethyl-4-methyl-5-(methylsulfonyloxymethyl)oxolan-3-yl] acetate is sourced from PubChem (CID 118633386), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).